1. Kaplan-Meier estimated kidney graft and patient survival among patients with type 2 diabetes mellitus (T2DM), age 18–59 years, body mass index < 30 kg/m2 undergoing deceased-donor kidney transplantation alone (DDKA) or simultaneous pancreas–kidney transplan...
Kaplan-Meier estimated kidney graft and patient survival among patients with type 2 diabetes mellitus (T2DM), age 18–59 years, body mass index < 30 kg/m2 undergoing deceased-donor kidney transplantation alone (DDKA) or simultaneous pancreas–kidney transplantation (SPK) from 2000 through (A) Patient survival, SPK versus DDKA: 82.0% versus 75.5% (log-rank P=0.04). (B) Kidney graft survival, SPK versus DDKA: 75.2% versus 65.1% (log-rank P=0.004). (C) Death-censored kidney graft survival, SPK versus DDKA: 86.2% versus 82.6% (log-rank P=0.21).
Alexander C. Wiseman, and Jane Gralla CJASN 2012;7:
©2012 by American Society of Nephrology